How have VIVE shares performed in 2024?

Viveve Medical's stock was trading at $0.0002 on January 1st, 2024. Since then, VIVE stock has increased by 0.0% and is now trading at $0.0002. View the best growth stocks for 2024 here .

When is Viveve Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 22nd 2024. View our VIVE earnings forecast .

How were Viveve Medical's earnings last quarter?

Viveve Medical, Inc. (NASDAQ:VIVE) posted its quarterly earnings results on Thursday, November, 11th. The company reported ($0.67) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.58) by $0.09. The business had revenue of $1.62 million for the quarter. During the same period last year, the business earned ($2.60) earnings per share.

What other stocks do shareholders of Viveve Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP) , Visa (V) , HP (HPQ) , Fortive (FTV) , Lowe's Companies (LOW) , SCYNEXIS (SCYX) , Western Digital (WDC) , Inovio Pharmaceuticals (INO) , Viking Therapeutics (VKTX) and Novavax (NVAX) .

When did Viveve Medical IPO?

Viveve Medical (VIVE) raised $13 million in an initial public offering (IPO) on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group served as the underwriters for the IPO and Maxim Group was co-manager.

How do I buy shares of Viveve Medical?

Shares of VIVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:VIVE

Viveve Medical (VIVE) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free VIVE Stock Alerts

$0.0002

0.00 (0.00%)

(As of 04/19/2024 ET)

Compare

Today's Range: $0.0002
▼
$0.0002
50-Day Range: N/A
52-Week Range: $0.00
▼
$0.11

Volume: 1,404 shs
Average Volume: 3,365 shs
Market Capitalization: $2,144.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Social Media

Get Viveve Medical alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Viveve Medical Stock (NASDAQ:VIVE)

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

VIVE Stock Price History

30 days | 90 days | 365 days | Advanced Chart

VIVE Stock News Headlines

April 17, 2024 | finance.yahoo.com

5-Alpha Reductase Deficiency Global Market Report 2024: A $1.94 Billion Projected Market in 2028

April 15, 2024 | finance.yahoo.com

InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL

April 20, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

February 23, 2024 | benzinga.com

Viveve Medical Stock (OTC:VIVE), Analyst Ratings, Price Targets, Predictions

July 29, 2023 | seekingalpha.com

VIVE Viveve Medical, Inc.

July 25, 2023 | finance.yahoo.com

InMode Expands Women's Health and Wellness Market Footprint through Acquisition of Viveve Patents

June 14, 2023 | uk.finance.yahoo.com

VIVE - Viveve Medical, Inc.

February 24, 2023 | finance.yahoo.com

Viveve Medical, Inc. (VIVE)

April 20, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

January 17, 2023 | msn.com

Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

January 17, 2023 | finanznachrichten.de

Viveve Medical, Inc.: Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence

January 17, 2023 | seekingalpha.com

Viveve crashes ~60% as company decides to delist, explore sale after trial fails

January 17, 2023 | finance.yahoo.com

Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence

January 17, 2023 | finance.yahoo.com

Viveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence Trial

January 17, 2023 | investorplace.com

Why Is Viveve Medical (VIVE) Stock Down 69% Today?

December 29, 2022 | insidermonkey.com

Viveve Medical, Inc. (NASDAQ:VIVE) Q3 2022 Earnings Call Transcript

December 15, 2022 | finance.yahoo.com

Viveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits Concluded

December 1, 2022 | finanznachrichten.de

Viveve Medical, Inc.: Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence

December 1, 2022 | finance.yahoo.com

Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence

November 13, 2022 | finance.yahoo.com

Viveve Medical Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag

November 10, 2022 | finanznachrichten.de

Viveve Medical, Inc.: Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update

November 10, 2022 | finance.yahoo.com

Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update

October 27, 2022 | finance.yahoo.com

Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022

October 25, 2022 | finance.yahoo.com

Global Cosmetic Gynecology Market Report to 2027 - Featuring Alma Laser, Lutronic, Viveve Medical and Venus Concept Among Others

October 13, 2022 | forbes.com

Viveve Medical

October 4, 2022 | finanznachrichten.de

Viveve Medical, Inc.: Viveve Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary Incontinence

October 4, 2022 | finance.yahoo.com

Viveve Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary Incontinence

See More Headlines

Receive VIVE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viveve Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/11/2021
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: NASDAQ:VIVE
Previous Symbol: OTCMKTS:PLCSD
CUSIP: N/A
CIK: 879682
Web: www.viveve.com
Phone: (720) 696-8100
Fax: 720-696-8199
Employees: 47
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $6.43 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 10,720,000
Free Float: 10,110,000
Market Cap: $3,216.00
Optionable: Not Optionable
Beta: 0.08

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Jim B. Robbins (Age 60)
Senior VP of Finance & Administration and Principal Accounting & Financial Officer
Comp: $386.94k
Ms. Deborah Ann Jorn M.B.A. (Age 66)
Senior Advisor to the CEO & Director
Comp: $35k
Mr. Martin Kerber P.E.
Vice President of Research, Development & Operations
Ms. Jeannie Swindle
Senior Director of Corporate Communications
Mr. Jeff Sinclair
Vice President of International Sales
Mr. Gary Kaiser
Vice President of Global Marketing
Ms. Lori McMillan
Vice President of Human Resources
Ms. Suzon D. Lommel (Age 66)
Senior Vice President of Regulatory & Quality Affairs

Key Competitors

View All Competitors

VIVE Stock Analysis - Frequently Asked Questions

How have VIVE shares performed in 2024?: Viveve Medical's stock was trading at $0.0002 on January 1st, 2024. Since then, VIVE stock has increased by 0.0% and is now trading at $0.0002.
View the best growth stocks for 2024 here.
When is Viveve Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, April 22nd 2024.
View our VIVE earnings forecast.
How were Viveve Medical's earnings last quarter?: Viveve Medical, Inc. (NASDAQ:VIVE) posted its quarterly earnings results on Thursday, November, 11th. The company reported ($0.67) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.58) by $0.09. The business had revenue of $1.62 million for the quarter. During the same period last year, the business earned ($2.60) earnings per share.
What other stocks do shareholders of Viveve Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), HP (HPQ), Fortive (FTV), Lowe's Companies (LOW), SCYNEXIS (SCYX), Western Digital (WDC), Inovio Pharmaceuticals (INO), Viking Therapeutics (VKTX) and Novavax (NVAX).

When did Viveve Medical IPO?: Viveve Medical (VIVE) raised $13 million in an initial public offering (IPO) on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group served as the underwriters for the IPO and Maxim Group was co-manager.
How do I buy shares of Viveve Medical?: Shares of VIVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:VIVE) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Viveve Medical (VIVE) Stock Price, News & Analysis

About Viveve Medical Stock (NASDAQ:VIVE)

VIVE Stock Price History

VIVE Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

VIVE Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info